Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (7889)	5/29/1998 10:04:00 PM
From: Galirayo	Read Replies (1) \| Respond to of 9262

[ Bio Stos, Weds. data ] Rick, MATX ...... BSto, Next W ... looks like it's trying hard to pass the 300dma near 5.03. This will be it's 4th or 5th attempt at the 300. Maybe it'll get thru this time. It looks Very interesting. Any info you have handy? BTRN....... BSto ... unsure. Low Vol and just made it thu the 50dma. MDYN....... F&Slo ... needs to pass the 50dma near 13.12. Another interesting one. MEDX....... Next W .. No. I don't care much for this one today. It's saying consolidation. Cheers! Ray PS: I was talking about you tonite. ... Oh, gimme a break ... Good of course. And REGN was mentioned. Do you have any more thoughts or info on REGN? Message 4650717 Message 4650917

To: scaram(o)uche who wrote (7889)	6/4/1998 9:49:00 AM
From: Scott H. Davis	Read Replies (1) \| Respond to of 9262

[LGND TA question & intro to Richard H.] I've been looking at LGND for a while, and the price response did not seem to follow most of this Spring's news & clinical development. Now, news on an FDA comittee recomendation was very mixed - they were recommending approval of a med, but only as a therapy of last resort type due to the significant side effects/toxicity. Price is dropping. I'm not a TA heavy - my expertise is more in FA and business case (I'm a long term, consulting level clinical systems analyst with a degree in Business Adm) I see some support at 12. What do ya'll see. Richard, I have been exchanging with Rainier for about a year, on EQNX, PERLF, QSNDF and a lot on The Rational Analyst. My main focus this year is in biotechs and computer networking stocks (I've decided to concentrate on healthcare and info. systems since I have the background to appreciate the business case, rather than oil...) Anyway, Rainier has suggested I contact you and perhaps do some things jointly with you. Looking at your profile I understand why. I also noticed VICL was not in your list, but seemed to meet some of your criteria. Based on the pipeline depth, stage of clinical development, revenue potential, technology platform and liquid reserves, what are your top 2 or 3. I noticed AGPH, which I'm also getting interested in (Viracept in 38 months was very impressive) Thanks, Scott